The Food and Drug Administration today announced a voluntary pilot program to expedite approvals of certain changes to ethylene oxide sterilization processes and facilities. Under the pilot program, facilities that use fixed-chamber ethylene oxide sterilization processes to sterilize single-use medical devices would submit a “master file” to the FDA when making certain changes to their location or changes to their sterilization processes that use lower ethylene oxide concentrations. The FDA believes the program will allow more efficient review and feedback, ultimately allowing the agency to provide a more nimble response to site closures in the future. In addition, FDA said it will work with 12 applicants to its innovation challenges to accelerate the development and review of innovative technologies for sterilization processes, and is moving forward with certain recommendations from its recent advisory committee meeting.

Related News Articles

Headline
Cordis Corporation recently recalled 25,000 catheters used to visualize and measure parts of the vascular system, due to the potential for their marker…
Headline
Based on lessons learned over the past decade, Centers for Medicare & Medicaid Services Administrator Chiquita Brooks-LaSure and other incoming CMS leaders…
Headline
Learn how AHA members are using digital solutions to improve perinatal care and outcomes for moms and their families in this series of seven-minute interviews…
Blog
The next generation of moms and families are more-frequently experiencing new tech-based approaches to improving one’s pregnancy or birthing journey. Digital…
Headline
Health care disruptors forged ahead in 2020 despite the pandemic, but hospitals and health systems can embrace the opportunities for collaboration and…
#HealthCareInnovation Thursday Blog
COVID-19 disrupted virtually every area of the economy in 2020. As businesses across all sectors hunkered down and focused on core operations and ways to…